Daiwa Securities Group
ALPN

Daiwa Securities Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

Daiwa Securities Group’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-238
Closed -$9K – 1381
2024
Q1 		$9K Hold
238
– – ﹤0.01% 1175
2023
Q4 		$5K Buy
238
+153
+180% +$2.13K ﹤0.01% 1213
2023
Q3 		$1K Hold
85
– – ﹤0.01% 1284
2023
Q2 		$1K Hold
85
– – ﹤0.01% 1311
2023
Q1 		$1K Hold
85
– – ﹤0.01% 1295
2022
Q4 		$1K Hold
85
– – ﹤0.01% 1303
2022
Q3 		$1K Hold
85
– – ﹤0.01% 1324
2022
Q2 		$1K Hold
85
– – ﹤0.01% 1336
2022
Q1 		$1K Hold
85
– – ﹤0.01% 1356
2021
Q4 		$1K Buy
+85
New +$1.05K ﹤0.01% 1369

Daiwa Securities Group's ALPN Position: Q2 2024 in Review

Daiwa Securities Group sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 238 shares — an estimated $9K sold.

Daiwa Securities Group first reported a position in ALPN in Q4 2021 and held it in 10 quarters. The position peaked at $9K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Daiwa Securities Group reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 238 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $9K.
  • Daiwa Securities Group first reported a position in Alpine Immune Sciences Inc in Q4 2021 and held it in 10 quarters.
  • Daiwa Securities Group's Alpine Immune Sciences Inc position peaked at $9K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Daiwa Securities Group's 13F filing for Q2 2024, filed 7 Aug 2024.